Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin

This publication has 23 references indexed in Scilit:

• Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
  New England Journal of Medicine, 2005
• Reticulated platelets in acute coronary syndrome: A marker of platelet activity
  Journal of the American College of Cardiology, 2004
• Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack
  British Journal of Haematology, 2004
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Evaluation of Platelet Function by Flow Cytometry
  Methods, 2000
• Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
  The Lancet, 1999
• Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.
  Journal of Clinical Investigation, 1997
• Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of Thromboxane
  Journal of Biological Chemistry, 1996
• Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
• The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
  Journal of Clinical Investigation, 1975